WebQuaker Houghton develops, produces, and markets a broad range of formulated specialty chemical products and offers chemical management services (“Fluidcare”) for various industrial and manufacturing applications throughout its four segments: Americas; … WebFeb 23, 2024 · QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS • Q4’22 net sales of $484.8 million increased 8% compared to Q4’21 driven by higher selling prices • Record full year 2024 net sales of $1.9 billion primarily driven by value-based pricing initiatives
Investor Presentation Investor Relations Quaker Houghton
WebQUAKER CHEMICAL CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. WebFeb 10, 2024 · CONSHOHOCKEN, Pa., Feb. 10, 2024 /PRNewswire/ -- Quaker Houghton (NYSE: KWR) today announced the following schedule and contact information for its fourth quarter and full year 2024 earnings release and investor call. About Quaker Houghton Quaker Houghton (NYSE: KWR) is the global leader in industrial process fluids. kv schule solothurn
2008 Quaker Chemical Corporation Annual Report - Issuu
WebApr 11, 2024 · Quaker Chemical Co. (NYSE:KWR – Get Rating) declared a quarterly dividend on Wednesday, February 22nd, RTT News reports. Shareholders of record on Friday, April 14th will be paid a dividend of 0.435 per share by the specialty chemicals company on Friday, April 28th. This represents a $1.74 dividend on an annualized basis and a dividend … WebDec 31, 2024 · QUAKER CHEMICAL CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ÈANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For … WebNov 3, 2024 · QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2024 RESULTS Record net sales of $492.4 million increased 13% compared to Q2’21 driven by higher selling prices Reported net income of $14.3 million and earnings per diluted share of $0.80 Delivered $58.5 million of adjusted EBITDA and $1.32 of non-GAAP earnings per diluted share pro medicus ltd stock